Sat, Aug 2, 2014, 2:00 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Skullcandy, Inc. (SKUL) Message Board

cash2go 115 posts  |  Last Activity: Jul 31, 2014 8:22 PM Member since: Feb 8, 2006
  • Reply to

    please read

    by pagesus52 Jul 31, 2014 7:56 PM
    cash2go cash2go Jul 31, 2014 8:22 PM Flag

    At least give the healthworkers the choice. Lowest dose with potential that has potential to incrase the potential of survival?

    FDA needs to get over their "God Complex".

  • Picosure becoming a blockbuster for Cynosure?

    People Magazine
    Breaking Up Is Hard 'Tattoo': 7 Celebs Who Have Removed Their Ex-Themed Ink

    * Reading the article I'm thinking there will be much more money to be made in the removal of tattoos than money made during the tattoo craze. Removing a tattoo in 3 to 5 sessions versus 15 plus sessions...Picosure.

    Dissappointed I didn't get a big discount today to collect shares

  • Reply to

    another strong quarter for picosure

    by cash2go Jul 29, 2014 4:52 PM
    cash2go cash2go Jul 30, 2014 1:41 AM Flag

    wftglo - I'm more amazed at how many tattoos people are currently getting. Life goes on and a few of those tattoos on each person have to be HUGE regrets. Then you have the age thing....

    Totally sold on Cynosure when a sight I regularly visit "MedPage Today" had a midyear update on the Prediction Issue from January. You can visit the site and see the Dermatology update. Dr Avram updates his prediction on Picosure as starting to make a big impact on tattoo removal. According to him nothing compares to this advance in tattoo removal.
    Anyone googling tattoo removal is going to be impressed as testimonials abound on how much better this system works. It's a huge worldwide market and Cynosure will be seeing an explosion of orders for the machines due to public demand.

    $$$, Wall Street actually has good coverage of this stock and is no doubt seeing the Picosure value being realized in their $35 to $42 targets. Could be a very good August to be in this stock.

    Congrats to all

  • Cynosure mentions it in their review for the quarter. Wall Street doesn't yet fully understand the size of the tattoo removal market:

    Tattoo Removal: A Bigger Business than Tattooing
    Hilary Kramer Posted: 02/24/10

    ...Dr. Tatoff, which currently operates three clinics in the Los Angeles area, is planning to become a publicly traded company and that will trade on a market exchange such as NASDAQ. "We anticipate being publicly traded during 2010 and having close to 10 locations operational or in the start-up phase by then." This makes sense given the magnitude of the money-making opportunity. According to Keefe, there are 7 million people wanting to remove their tattoos and, given that the cost will run more than $1,500 each, then this could easily be more than a $10 billion industry.

  • cash2go cash2go Jul 29, 2014 2:22 AM Flag

    bigs,
    If a patient has multiple readmissions. as I understand it, each one count towards the #187 look see.

  • "The population is adult patients, 18 to 80 years of age, with NYHA class III/IV symptoms of heart failure due to ischemic or non-ischemic cardiomyopathy, and who, despite maximal optimized heart failure therapy regimens, are at high risk of heart failure-related hospitalizations. A total of 250 patients (N= ~125 per treatment arm) were enrolled for the purpose of obtaining at least 186 adjudicated heart failure-related hospitalizations."

    (Looks like it could be obvious when 186 rehospitilizations are reached that a vast majority will be the non-treatment arm), should be well before 2015?

    GLTA

  • cash2go cash2go Jul 24, 2014 1:01 AM Flag

    looks like the author is about a year late on prices. That would give us $3305 Zinc in 2015.

    I've dug a little on future mines to come on line in the next few years. Looks like 3 of the biggest 5 zinc mines in the world will be depleted in the within the next year. It also looks like nobody has anything close to those even in the planning stage and once planning has started expect 5 to 10 years before significant production will be seen.

    If anyone can correct me on that please post.

  • cash2go cash2go Jul 24, 2014 12:55 AM Flag

    Quick hard dips followed by rip your face off rallies. I honestly think the little guys trying to trade this are losing money. I'm guessing a couple of weeks into August and the long term investors will start to see where the real trend is in the stock price.

    GLTA. Glad I know I suck at day trading and haven't tried day trading this one.

  • See "Medpage Today"

    Prediction Update: Dermatology (guess what the Doctor selected as the biggest news for 2014 to date) Picosure.

    You have to register as a doctor to hear the review. It's an impressive site and an impressive review of what Picosure is doing for tattoo removal, a service that is growing at extreme rate. Some tattoos can be removed in 3 to 5 appointments versus 15 plus plus plus for many other lasers.

    Also check "RealSelf" and look under tattoo removal to see what actual people are saying about Picosure tattoo removal versus what they have experienced with other lasers.

    GLTA

  • Zinc Price Forecast

    Indeed, these junior companies are bound to be in focus over the medium term, with zinc prices expected to take off in 2016. CRU International forecasts that the real three-month price of zinc, defined as the nominal price/US consumer price index, will go from US$2,125 in 2012, to US$2,455 in 2015, and US$3,305 in 2016.

    The nominal three-month price per pound is expected to go up to 161 cents in 2016 from 96.4 cents per pound in 2012.

    (nice accuracy from 2012, buy the dips and hold for the long term) GLTA

  • Reply to

    Financial Times and now Barrons

    by cash2go Jul 22, 2014 12:44 AM
    cash2go cash2go Jul 22, 2014 1:00 AM Flag

    Barrons'

    Aticle very high on the new low cost Mooresboro NC plant ramping up with cost expected around 40 to 50 cents per pound.
    Best you can do now is 80 cents out of ground and those cheaper mines are going out of business. Where will the stock price be by the fourth quarter of '14, 30 plus.

    GLTA

  • Financial Times
    April 24, 2014 7:09 pm

    ...Several large mines, including Century in Australia and Lisheen in Ireland are expected to shut in 2015.
    “Over a three-year period commencing last year, approximately 1.5m tonnes of current zinc production will be closed due to mine depletion. This is a significant figure in a 13m tonne market,” said chief executive Don Lindsay on a call with analysts.

  • So many "me too" drugs that do the same thing and one will be made in US. Which drug should be designated preffered drug on US formularies? The US citizens will make sure the business you developed by charging US customers up to 10 times what other countries pay doesn't take this lying down.

    Bye-bye #$%$.

  • cash2go by cash2go Jul 14, 2014 2:54 PM Flag

    Are investors selling hoping buy back after lockup expiration date?

    Are there day traders playing with this stock still trying to make money on a daily bounce?

    How low do you guys think this one can go? No volume makes me think we are seeing artificial prices reached by the boys trading between each other to see if they can cause a panic sell into a spiral?

    GLTA, would love more at lower prices

  • cash2go cash2go Jul 14, 2014 2:34 PM Flag

    What did the FDA have to see before giving BreakThrough status:

    "This designation is intended to expedite the development and review of drugs for serious or life-threatening conditions and where (((preliminary clinical evidence suggests it provides a substantial improvement over existing therapies)))."

  • cash2go cash2go Jul 14, 2014 2:30 PM Flag

    First drug trial where I've seen an SPA that set the primary point as Readmissions. Looks like the FDA looked at the updated 3 year results on the high dose patients and were convinced that Mydicar has the potential to save billions of $ in health care costs every year. And, approved (SPA) readmissions as a primary endpoint.

    GLTA

  • cash2go cash2go Jul 14, 2014 2:22 PM Flag

    Found an interesting article:
    A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8

    "we showed that after 1–5 PPs performed in a short period of time, NAF specific for AAV2, 1, 6, and 8 became undetectable for some patients when initial titers at the screening steps were ≤1:20. Furthermore, it was also possible to reduce the NAF titer to 1:5–1:2 but also for patients with low initial titers (≤1:20). Overcoming these residual NAF can be achieved by increasing vector dose, as previously described."

    If you were aware of that information and you were talking to BIG Pharma about Mydicar would you sell the rights before a Plasmapheresis trial had the potential to add billion more to the sell price

  • cash2go cash2go Jul 14, 2014 2:13 PM Flag

    It's a multibillion dollar drug if it improves on decreasig readmission rates if given at highest dose. Mydicar was able to reduce readmission rates for six months at the lower dose levels.
    (Is this latest trial to makes sure you can't treat the additional 60% and get a $10B buyout price)

    Piced up more at $12.50, thanks yall'

  • cash2go cash2go Jul 10, 2014 2:21 AM Flag

    My hope for the lockup is that there are enough anxious sellers to create some cheap shares to be bought by long term buyers.

    I'm comfortable with my holding but would love to pick up more shares at a cheaper price

  • cash2go cash2go Jul 8, 2014 2:56 AM Flag

    First Cupid trial, many years ago:

    "Only patients with undetectable neutralizing antibodies against AAV1 (titer

SKUL
7.39+0.63(+9.32%)Aug 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Berkshire Hathaway Inc.
NYSEFri, Aug 1, 2014 4:02 PM EDT
Tesla Motors, Inc.
NasdaqGSFri, Aug 1, 2014 4:00 PM EDT